Re:course AI, the artificial intelligence (AI) flight simulator for healthcare training, has received $4.3 million in seed funding from Par Equity, Northern Gritstone, the GMC Life Sciences Fund By Praetura, Rob Wood, and the Current Health founders.
The company is looking to expand its engineering team and enter new markets at a time when the global healthcare industry needs to address chronic staffing shortages, the accelerating pace of life sciences innovation, and patient outcomes expectations. Re:course AI, which is already being used in healthcare institutions in the United States and the United Kingdom, will train doctors and nurses on a large scale.
“Re:course AI has the potential to disrupt how the healthcare professionals of the future are trained, as the demand for virtual AI-based training is growing,” Aidan MacMillan, Senior Investment Manager, Par Equity. “The medical and AI capability within Re:course AI has enabled a unique approach to training for healthcare and life sciences professionals which can handle a wide variety of real world scenarios. We are excited to be supporting Scott, Maksim and the rest of the Re:course AI team at this important step in their journey.”
Re:course AI is a deeptech company on a mission to acceleratehuman performance using AI-powered virtual training. Founded by Dr. ScottMartin, Clinical Entrepreneur Fellow at NHS England and CEO at Re:course AI,and Maksim Belousov, PhD in Artificial Intelligence/Natural Language Processingand CTO, the team has developed a flight simulator using fully conversational,voice-interactive Digital Human Patient avatars that provide a uniqueopportunity to support medical professionals by bridging the gap betweentraditional training and real-world scenarios.
